Search

Your search keyword '"Ottestad, L."' showing total 50 results

Search Constraints

Start Over You searched for: Author "Ottestad, L." Remove constraint Author: "Ottestad, L."
50 results on '"Ottestad, L."'

Search Results

1. Mendelian randomisation study of smoking exposure in relation to breast cancer risk

2. Mendelian randomisation study of smoking exposure in relation to breast cancer risk.

3. CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers.

4. Common variants in breast cancer risk loci predispose to distinct tumor subtypes

5. Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk.

6. Two truncating variants in FANCC and breast cancer risk

7. Two truncating variants in FANCC and breast cancer risk

8. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes

9. Polygenic risk scores for prediction of breast cancer and breast cancer subtypes

10. Changes in bone metabolism after 2 years’ treatment with exemestane (E) in postmenopausal women with early breast cancer (EBC) at low risk: Follow-up (FU) results of a randomized placebo-controlled study

11. Effects of tamoxifen and octreotide LAR on the IGF-system compared with tamoxifen monotherapy

24. Neuron specific enolase-positive breast carcinomas

25. Screening for germ line TP53 mutations in breast cancer patients

26. Historical Biobanks in Breast Cancer Metabolomics- Challenges and Opportunities.

27. Observational study of everolimus plus exemestane in postmenopausal women with hormone receptor-positive, HER2-negative advanced breast cancer.

28. DNA methylation signature (SAM40) identifies subgroups of the Luminal A breast cancer samples with distinct survival.

29. Systematic analysis of challenge-driven improvements in molecular prognostic models for breast cancer.

30. Gefitinib in Combination with Weekly Docetaxel in Patients with Metastatic Breast Cancer Caused Unexpected Toxicity: Results from a Randomized Phase II Clinical Trial.

31. Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026].

32. [Breast cancer patients' assessment of waiting time before radiotherapy].

33. Randomized, placebo-controlled trial of clodronate in patients with primary operable breast cancer.

34. Expression of EGFR family and steroid hormone receptors in ductal carcinoma in situ of the breast.

35. Influence of neoadjuvant anastrozole (Arimidex) on intratumoral estrogen levels and proliferation markers in patients with locally advanced breast cancer.

36. Loss of heterozygosity at 11q23.1 in breast carcinomas: indication for involvement of a gene distal and close to ATM.

37. [Chemotherapy-induced hemolytic uremic syndrome. A complication to mitomycin treatment of breast carcinoma].

38. Flow cytometric DNA analysis as prognostic factor in human breast carcinoma.

39. Amplification of c-erbB-2, int-2 and c-myc genes in node-negative breast carcinomas. Relationship to prognosis.

40. Screening for germ line TP53 mutations in breast cancer patients.

41. Genetic alterations of the tumour suppressor gene regions 3p, 11p, 13q, 17p, and 17q in human breast carcinomas.

43. The c-erbB-2 protein in primary and metastatic breast carcinomas.

44. C-erbB-2 protein and neuroendocrine expression in breast carcinomas.

45. Neuron specific enolase-positive breast carcinomas.

46. An ultrastructural study of benign and malignant breast epithelial cells. A search for tonofilaments.

48. An immunocytochemical method for assaying oestrogen receptors in breast cancers. A comparison with the steroid binding assay.

50. Neuroendocrine activity in metastatic breast carcinomas.

Catalog

Books, media, physical & digital resources